Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
permanent-hair-loss
Press Release
Dec 11, 2017
Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes
In this study of 5,000 women, more women who received Paclitaxel once a week were likely to be alive and free of breast cancer five years after being diagnosed compared to women who received Paclitaxel every three weeks OR women who received Docetaxel (either weekly or every three weeks).
Read More
Press Release
May 1, 2017
Women Are Fighting Back Against a Breast Cancer Chemotherapy Drug According to Consume Safety Watch
Read More
Press Release
Apr 22, 2017
Chemotherapy Manufacturer Hid Risk of Permanent Hair Loss, Exaggerated Success Rates, Warns Consumer Safety Watch
Read More
First
Prev
1
Next
Last